--- title: "EPIDAREX CAPITAL PARTNERS LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a json: https://whiteintel.dev/api/public/dossier/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a identifier: oo:GB-COH-SC437985 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # EPIDAREX CAPITAL PARTNERS LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-SC437985` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a ## Cross-source identity The same real-world entity, resolved across sources: - **Epidarex Capital Partners Limited** — source · `gb-coh:SC437986` — https://whiteintel.dev/entity/de59177c-d758-4181-abdd-e8e06fecf130 ## Ownership & control ### Owners / controllers - **Mr Andrew Sinclair Dunlop** (beneficial owner) — 50% — https://whiteintel.dev/entity/e83f2e98-3498-5b83-bd1c-acc0a8262318 - **Dr Elizabeth Ann Roper** (beneficial owner) — 50% — https://whiteintel.dev/entity/2264793c-6189-58d9-9b0d-9ba8718719b2 - **Ms Kyparissia Katie Sirinakis** (beneficial owner) — 50% — https://whiteintel.dev/entity/3aacd88d-fb41-505c-800c-85ff754fb8b7 - **Dr Peter Michael Finan** (beneficial owner) — 50% — https://whiteintel.dev/entity/0f27ec9b-e21c-5d58-8dbb-12bc4bc3043d - **Mr Andrew Sinclair Dunlop** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/6a0723e4-38a3-4076-ab83-352bcbf530a9 - **Ms Kyparissia Katie Sirinakis** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/9109559e-f635-4444-b012-e7494a97145b - **Dr Elizabeth Ann Roper** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f02cd628-7ffa-44b6-9564-61a81f6d4a01 - **Dr Peter Michael Finan** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/9026be56-6184-4440-bb2c-d3f50693ddb4 - **EPIDAREX MANAGEMENT LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/870ee214-4f1a-50e8-b995-7333a0013567 ### Holdings / subsidiaries - **EPSILOGEN LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/d5968523-527a-53a6-92a7-8451f78bf820 - **EPIDAREX CAPITAL II, LP** (beneficial owner) — https://whiteintel.dev/entity/7c669a1a-f152-53b2-9111-16bc3e6b9d02 - **ENTERPRISE THERAPEUTICS LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/4072bc90-158d-54d0-93b7-b7b54b04cd12 - **EPIDAREX CAPITAL III UK GP, LP** (beneficial owner) — https://whiteintel.dev/entity/d9b5919f-fcb9-5fee-a3e6-014aa383ad60 - **CALDAN THERAPEUTICS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3 - **ADORX THERAPEUTICS LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/f2773abd-96c4-55be-9b6f-e200ba9701c0 - **CLYDE BIOSCIENCES LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/9a1b86f0-cd9e-5e34-b667-79a2fb05523b - **EPIDAREX CAPITAL IV, LP** (beneficial owner) — https://whiteintel.dev/entity/36120514-a888-490c-aa3f-9af315e9ac03 - **EIF CO-INVEST LP** (beneficial owner) — https://whiteintel.dev/entity/9239ea4a-2c45-5753-b910-73c40f13d784 - **EPIDAREX CAPITAL UK GP, LLP** (beneficial owner) — https://whiteintel.dev/entity/3441f480-4a33-59ec-a998-06b050399556 - **EPIDAREX CAPITAL II GP, LP** (beneficial owner) — https://whiteintel.dev/entity/c3707402-00ab-5efa-9773-eeb395a3cdeb ### UBO chain (walk to the ultimate owner) A **15-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `SC437985` - **Status:** active - **Type:** ltd - **Incorporated:** 2012-11-30 - **Registered office:** 137a George Street, Edinburgh, EH2 4JY, Scotland - **SIC:** 66300 ### Officers - DUNLOP, Andrew Sinclair — director · British · appointed 2012-11-30 - FINAN, Peter Michael, Dr — director · British · appointed 2019-06-17 - ROPER, Elizabeth Ann, Dr — director · Irish · appointed 2013-10-01 - SIRINAKIS, Kyparissia Katie — director · American · appointed 2012-11-30 ### Beneficial owners (Persons with Significant Control) - [Epidarex Management Ltd](https://whiteintel.dev/entity/870ee214-4f1a-50e8-b995-7333a0013567) — 75–100% shares · corporate PSC · Scotland — since 2020-01-27 - Dr Peter Michael Finan — 25–50% shares · individual PSC · Scotland — ceased 2019-06-17 - Mr Andrew Sinclair Dunlop — 25–50% shares · individual PSC · Scotland — ceased 2019-06-17 - Dr Elizabeth Ann Roper — 25–50% shares · individual PSC · Scotland — ceased 2019-06-17 - Ms Kyparissia Katie Sirinakis — 25–50% shares · individual PSC · Scotland — ceased 2019-06-17 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/SC437985 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/SC437985 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **EPIDAREX CAPITAL PARTNERS LIMITED** — https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **EPIDAREX CAPITAL PARTNERS LIMITED**. Human view: https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a · Structured JSON: https://whiteintel.dev/api/public/dossier/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._